Local-Regional Recurrence (LRR) Data from the American College of Surgeons Oncology Group (ACOSOG) Z1041 (Alliance): A Randomized Neoadjuvant Trial of Sequential Versus Concurrent Anthracycline with Trastuzumab and Paclitaxel Plus Trastuzumab in HER2-Positive (HER2+) Breast Cancer (BC)
      Google Scholar   
Citation:
Ann Surg Oncol vol 26 (suppl 1) S5 abstr 1
Meeting Instance:
SSO 2019
Year:
2019
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                   
Networks:
LAPS-MN026, LAPS-TX011, LAPS-TX035, NEWMEXICO, TX041, TX190   
Study
ACOSOG-Z1041
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: